CA1140466A - Produits pharmaceutiques - Google Patents

Produits pharmaceutiques

Info

Publication number
CA1140466A
CA1140466A CA000368219A CA368219A CA1140466A CA 1140466 A CA1140466 A CA 1140466A CA 000368219 A CA000368219 A CA 000368219A CA 368219 A CA368219 A CA 368219A CA 1140466 A CA1140466 A CA 1140466A
Authority
CA
Canada
Prior art keywords
amount
agent
pharmaceutical composition
sustained release
per tablet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000368219A
Other languages
English (en)
Inventor
John F. Lampard
James M. Dunn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boots Co PLC
Original Assignee
Boots Co PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/194,453 external-priority patent/US4308251A/en
Application filed by Boots Co PLC filed Critical Boots Co PLC
Application granted granted Critical
Publication of CA1140466A publication Critical patent/CA1140466A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA000368219A 1980-01-11 1981-01-09 Produits pharmaceutiques Expired CA1140466A (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11143080A 1980-01-11 1980-01-11
US111,430 1980-01-11
US06/194,453 US4308251A (en) 1980-01-11 1980-10-17 Controlled release formulations of orally-active medicaments
US194,453 1980-10-17

Publications (1)

Publication Number Publication Date
CA1140466A true CA1140466A (fr) 1983-02-01

Family

ID=26808896

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000368219A Expired CA1140466A (fr) 1980-01-11 1981-01-09 Produits pharmaceutiques

Country Status (22)

Country Link
JP (1) JPS56103110A (fr)
AT (1) AT374681B (fr)
AU (1) AU542824B2 (fr)
BE (1) BE886998A (fr)
CA (1) CA1140466A (fr)
CH (1) CH646604A5 (fr)
DE (1) DE3100191A1 (fr)
DK (1) DK6181A (fr)
ES (2) ES498369A0 (fr)
FI (1) FI76927C (fr)
FR (1) FR2473308B1 (fr)
GB (1) GB2067072B (fr)
GR (1) GR73843B (fr)
IE (1) IE50806B1 (fr)
IN (1) IN151913B (fr)
IT (1) IT1221041B (fr)
LU (1) LU83052A1 (fr)
NL (1) NL8100037A (fr)
NO (1) NO156153C (fr)
NZ (1) NZ195933A (fr)
SE (1) SE447450B (fr)
ZA (1) ZA81136B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2496082A (en) * 1947-05-24 1950-01-31 Ashenfelter William Scaffold structure
IT1144911B (it) * 1981-03-19 1986-10-29 Pharmatec Spa Composizione farmaceutica a rilascio controllato contenente ibuprofen
JPS59227817A (ja) * 1983-06-07 1984-12-21 Toyo Jozo Co Ltd 持続性経口用ブレデニン製剤
JPH0662404B2 (ja) * 1983-06-14 1994-08-17 シンテックス・ファーマシユーテイカルズ・インターナシヨナル・リミテツド 制御放出性ナプロキセンおよびナプロキセンナトリウム錠
ZA836030B (en) * 1983-08-16 1985-02-27 Verex Lab Constant order release solid dosage indomethacin formulation and method of treating arthritis and other inflammatory conditions
ZA836031B (en) * 1983-08-16 1985-02-27 Verex Lab Constant release rate solid dosage theophylline formulation
EP0138216B1 (fr) * 1983-10-14 1993-01-07 Sumitomo Pharmaceuticals Company, Limited Préparation IFN à libération prolongée pour administration par voie parentérale
US4855134A (en) * 1983-10-14 1989-08-08 Sumitomo Pharmaceuticals Company, Limited Sustained-release preparation
US5385738A (en) * 1983-10-14 1995-01-31 Sumitomo Pharmaceuticals Company, Ltd. Sustained-release injection
US4774091A (en) * 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
ATE87469T1 (de) * 1985-12-27 1993-04-15 Sumitomo Pharma Verfahren zur herstellung einer formulierung mit verzoegerter freisetzung.
GB8601204D0 (en) * 1986-01-18 1986-02-19 Boots Co Plc Therapeutic agents
US4968508A (en) * 1987-02-27 1990-11-06 Eli Lilly And Company Sustained release matrix
ZA881301B (en) * 1987-02-27 1989-10-25 Lilly Co Eli Sustained release matrix formulations
US5855915A (en) 1995-06-30 1999-01-05 Baylor University Tablets or biologically acceptable implants for long-term antiinflammatory drug release

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2953497A (en) * 1953-06-03 1960-09-20 Howard A Press Therapeutic tablets
NL128902C (fr) * 1960-06-06
US3577514A (en) * 1968-06-10 1971-05-04 Pfizer Sustained release pharmaceutical tablets
US3773920A (en) * 1971-07-14 1973-11-20 Nikken Chemicals Co Ltd Sustained release medicinal composition
US3906086A (en) * 1971-07-19 1975-09-16 Richard G Powers Timed-release aspirin
GB1500300A (en) * 1975-01-06 1978-02-08 Ciba Geigy Ag Pharmaceutical preparation for the treatment of circulatory disorders
JPS5411226A (en) * 1977-06-24 1979-01-27 Shin Etsu Chem Co Ltd Disintegratable granule

Also Published As

Publication number Publication date
AU542824B2 (en) 1985-03-14
ES509179A0 (es) 1982-12-16
FI76927B (fi) 1988-09-30
FR2473308B1 (fr) 1985-07-19
ES8205353A1 (es) 1982-06-01
NO156153B (no) 1987-04-27
CH646604A5 (fr) 1984-12-14
ATA5481A (de) 1983-10-15
NO810062L (no) 1981-07-13
FI76927C (fi) 1989-01-10
SE8100104L (sv) 1981-07-12
NZ195933A (en) 1982-11-23
DE3100191C2 (fr) 1988-09-01
IE50806B1 (en) 1986-07-23
DE3100191A1 (de) 1981-12-10
AU6597681A (en) 1981-07-16
ZA81136B (en) 1982-01-27
IN151913B (fr) 1983-09-03
GB2067072B (en) 1983-08-10
ES8301629A1 (es) 1982-12-16
IE810036L (en) 1981-07-11
IT1221041B (it) 1990-06-21
GR73843B (fr) 1984-05-07
IT8147537A0 (it) 1981-01-09
JPS56103110A (en) 1981-08-18
LU83052A1 (fr) 1982-09-10
NL8100037A (nl) 1981-08-03
BE886998A (fr) 1981-07-08
GB2067072A (en) 1981-07-22
FR2473308A1 (fr) 1981-07-17
ES498369A0 (es) 1982-06-01
FI810056L (fi) 1981-07-12
NO156153C (no) 1987-08-05
SE447450B (sv) 1986-11-17
DK6181A (da) 1981-07-12
AT374681B (de) 1984-05-25

Similar Documents

Publication Publication Date Title
US4308251A (en) Controlled release formulations of orally-active medicaments
CA1140466A (fr) Produits pharmaceutiques
EP0290168B1 (fr) Matrice d'ibuprofen à libération retardée et procédé
AU616449B2 (en) Controlled release combination of carbidopa/levodopa
US4375468A (en) Constant order release aspirin composition and method of treating arthritis
US4900755A (en) Controlled release combination of carbidopa/levodopa
US5529783A (en) Rotor granulation and coating of acetaminophen, pseudoephedrine, chlorpheniramine, and, optionally dextromethorphan
US4900558A (en) Sustained release ibuprofen formulation including a core of ibuprofen and a microcrystalline cellulose and a covering of acrylic polymer and hydroxylated cellulose derivative
EP0253490B1 (fr) Association carbidopa-levodopa à libération contrôlée
US4983400A (en) Controlled release combination of carbidopa/levodopa
FI96095C (fi) Menetelmä jatkuvavapautteisen lääkevalmisteen valmistamiseksi
EP0221732A2 (fr) Comprimés à effet retardé
US4867987A (en) Pharmaceutical product for the sustained release of ibuprofen
US3524910A (en) Sustained relief analgesic compositions
US3039933A (en) Ethyl cellulose-polyethylene glycol tablet matrix
US5589191A (en) Slow-release sodium valproate tablets
US4601895A (en) Delayed-action acetylsalicylic acid formulations for oral administration
WO2002020090A2 (fr) Compositions pharmaceutiques
AU2002213900A1 (en) Pharmaceutical compositions
JPS6087216A (ja) 一定放出性固体投薬形インドメタシン組成物および関節炎その他の炎症性状態の治療法
JP2638604B2 (ja) 徐放性製剤
JPH0899875A (ja) ゲンフィブロジル含有製剤組成物およびその製造法
CN116966157B (zh) 一种茶碱缓释片及其制备方法
JP3202775B2 (ja) 固形製剤
SE452550B (sv) Tablett med fordrojd frigoring av teofyllin

Legal Events

Date Code Title Description
MKEX Expiry